oa SA Pharmaceutical Journal - New product focus - Adacel Quadra™ : drug info

Volume 76, Issue 10
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



There has been a resurgence in the incidence of pertussis in several countries. There has also been a shift in the age distribution of pertussis, with dramatic increases being reported among adolescents and adults. It appears, therefore, that immunity to pertussis, whether acquired from natural infection during childhood or whether acquired from routine infant immunisation, may not be lifelong. Indeed, it has been shown that the duration of protection from both whole cell and acellular pertussis vaccine is six years, while natural infection may provide protection for up to 15 years.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error